Locke, F. L., Ghobadi, A., Jacobson, C. A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O., . . . Neelapu, S. S. (2018). Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): A single-arm, multicentre, phase 1-2 trial. Lancet Oncol.
Style de citation ChicagoLocke, Frederick L., et al. "Long-term Safety and Activity of Axicabtagene Ciloleucel in Refractory Large B-cell Lymphoma (ZUMA-1): A Single-arm, Multicentre, Phase 1-2 Trial." Lancet Oncol 2018.
Style de citation MLALocke, Frederick L., et al. "Long-term Safety and Activity of Axicabtagene Ciloleucel in Refractory Large B-cell Lymphoma (ZUMA-1): A Single-arm, Multicentre, Phase 1-2 Trial." Lancet Oncol 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.